Airspace dimension assessment with nanoparticles (AiDA) is a novel method to measure distal airspace radius non-invasively. In this study, AiDA radii were measured in 618 individuals from the population-based Swedish CArdiopulmonary BioImaging Study, SCAPIS. Subjects with emphysema detected by computed tomography were compared to non-emphysematous subjects. The 47 individuals with mainly mild-to-moderate visually detected emphysema had significantly larger AiDA radii, compared with non-emphysematous subjects (326±48 μm vs 291±36 μm); OR for emphysema per 10 μm: 1.22 (1.13-1.30, p<0.0001). Emphysema according to CT densitometry was similarly associated with larger radii compared with non-emphysematous CT examinations (316±41 μm vs 291 μm±26 μm); OR per 10 μm: 1.16 (1.08-1.24, p<0.0001). The results are in line with comparable studies. The results show that AiDA is a potential biomarker for emphysema in individuals in the general population.

Original languageEnglish
Pages (from-to)1040-1043
Issue number10
Early online date2021
Publication statusPublished - 2021

Subject classification (UKÄ)

  • Respiratory Medicine and Allergy
  • Radiology, Nuclear Medicine and Medical Imaging


  • emphysema
  • exhaled airway markers
  • imaging/CT MRI
  • respiratory measurement


Dive into the research topics of 'Airspace dimension assessment with nanoparticles as a proposed biomarker for emphysema'. Together they form a unique fingerprint.

Cite this